The looming antibiotic-resistance crisis has penetrated the consciousness of clinicians,
researchers, policymakers, politicians and the public at large. The evolution and widespread …

Inadequate dosing and incomplete treatment regimens, coupled with the ability of the
tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have …

Tuberculosis (TB) remains a global public health problem in recent years. TB originated
mainly from various strains of Mycobacterium tuberculosis, is a highly infectious and chronic …

Bacterial morphology is extremely diverse. Specific shapes are the consequence of adaptive
pressures optimizing bacterial fitness. Shape affects critical biological functions, including …

Tuberculosis is a contagious disease with comparatively high mortality worldwide. The
statistics shows that around three million people throughout the world die annually from …

Antibiotic resistance is a problem that continues to challenge the healthcare sector. In
particular, multidrug resistance is now common in familiar pathogens such as …

The cytoskeletal protein, FtsZ plays a pivotal role in prokaryotic cell division and is present in
majority of the bacterial species. In recent years, inhibitors of FtsZ have been identified that …

Tuberculosis (TB) and Cancer remains a global public health problem in recent years. There
is an urgent need for the screening of new bioactive molecules with new targets and with a …

Bacterial DNA gyrase is a well-established and validated target for the development of novel
antibacterials. Starting from the available structural information about the binding of the …

Ever since the world‐shaping discovery of penicillin, nature's molecular diversity has been
extensively screened for new medications and lead compounds in drug discovery. The …